X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
aged (10) 10
breast cancer (10) 10
female (10) 10
humans (10) 10
breast neoplasms - drug therapy (9) 9
index medicus (9) 9
middle aged (9) 9
oncology (9) 9
adult (8) 8
antineoplastic combined chemotherapy protocols - therapeutic use (8) 8
hematology, oncology and palliative medicine (8) 8
breast neoplasms - pathology (6) 6
chemotherapy (6) 6
therapy (6) 6
aged, 80 and over (5) 5
antineoplastic combined chemotherapy protocols - adverse effects (5) 5
cancer (5) 5
research (5) 5
antibodies, monoclonal, humanized - administration & dosage (4) 4
antimitotic agents (4) 4
antineoplastic agents (4) 4
bevacizumab (4) 4
breast neoplasms - mortality (4) 4
care and treatment (4) 4
chemotherapy, adjuvant (4) 4
metastasis (4) 4
neoplasm staging (4) 4
oncology, experimental (4) 4
receptor, erbb-2 - metabolism (4) 4
analysis (3) 3
breast neoplasms - chemistry (3) 3
cancer therapies (3) 3
docetaxel (3) 3
follow-up studies (3) 3
neoplasm recurrence, local - drug therapy (3) 3
paclitaxel (3) 3
paclitaxel - administration & dosage (3) 3
paclitaxel - therapeutic use (3) 3
patients (3) 3
receptor, erbb-2 - analysis (3) 3
survival (3) 3
survival rate (3) 3
time factors (3) 3
treatment outcome (3) 3
young adult (3) 3
adolescent (2) 2
angiogenesis inhibitors (2) 2
antibodies, monoclonal, humanized - therapeutic use (2) 2
breast neoplasms - metabolism (2) 2
cyclophosphamide - administration & dosage (2) 2
disease-free survival (2) 2
doxorubicin - administration & dosage (2) 2
epirubicin (2) 2
fluorouracil - administration & dosage (2) 2
fluorouracil - therapeutic use (2) 2
further section · weitere sektionen (2) 2
medical colleges (2) 2
neoadjuvant therapy (2) 2
neoplasm metastasis (2) 2
neoplasm recurrence, local - pathology (2) 2
product development (2) 2
prognosis (2) 2
receptors, estrogen - analysis (2) 2
safety (2) 2
taxoids - administration & dosage (2) 2
trastuzumab (2) 2
adenocarcinoma - chemistry (1) 1
adenocarcinoma - drug therapy (1) 1
adenocarcinoma - pathology (1) 1
adjuvant chemotherapy (1) 1
adjuvant trastuzumab (1) 1
adjuvant treatment (1) 1
anthracyclines (1) 1
anthracyclines - administration & dosage (1) 1
antibodies (1) 1
antibodies, monoclonal - administration & dosage (1) 1
antibodies, monoclonal - therapeutic use (1) 1
antibodies, monoclonal, humanized (1) 1
antibodies, monoclonal, humanized - adverse effects (1) 1
antibodies, monoclonal, humanized - pharmacokinetics (1) 1
antibody (1) 1
antineoplastic agents, hormonal - administration & dosage (1) 1
antineoplastic combined chemotherapy protocols - administration & dosage (1) 1
articles (1) 1
asia (1) 1
benefit (1) 1
bevacizumab - administration & dosage (1) 1
biomarkers (1) 1
biomarkers, tumor - antagonists & inhibitors (1) 1
biomarkers, tumor - metabolism (1) 1
brazil (1) 1
breast neoplasms - enzymology (1) 1
breast neoplasms - secondary (1) 1
breast neoplasms - surgery (1) 1
canada (1) 1
cancer och onkologi (1) 1
capecitabine (1) 1
capecitabine - administration & dosage (1) 1
chemotherapy, adjuvant - adverse effects (1) 1
chemotherapy, adjuvant - methods (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet, The, ISSN 0140-6736, 2013, Volume 381, Issue 9869, pp. 805 - 816
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2016, Volume 17, Issue 6, pp. 791 - 800
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2012, Volume 13, Issue 1, pp. 25 - 32
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2013, Volume 14, Issue 1, pp. 72 - 80
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2013, Volume 14, Issue 10, pp. 933 - 942
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2016, Volume 17, Issue 9, pp. 1230 - 1239
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2013, Volume 14, Issue 2, pp. 125 - 133
Journal Article